ACE inhibitor captopril has been shown to increase the sensitivity of drug-resistant breast cancer cells to tamoxifen in a mouse model25, which is consistent with the result from the clinical retrospective analysis that the combination of ACE inhibitors with standard chemotherapeutic drugs may improve the therapeutic effects in pancreatic and lung cancer26,27. The gene discussed is ACE; the disease is breast cancer.